Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.22 USD
12.01 M USD
128.26 M USD
33.20 M
About Lifecore Biomedical, Inc.
Sector
CEO
Paul Josephs
Headquarters
Chaska
Website
Founded
1965
FIGI
BBG000G1FS10
Lifecore Biomedical, Inc. engages in the development and manufacturing of pharmaceuticals products and services. It focuses on selling products utilizing hyaluronan, a naturally occurring polysaccharide that is widely distributed in the extracellular matrix of connective tissues in both animals and humans, and non-HA products for medical use primarily in the Ophthalmic, Orthopedic and other markets. The company was founded by Otto Sartorius in 1965 and is headquartered in Chaska, MN.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of LFCR is 7.31 USD — it has increased by 4.73% in the past 24 hours. Watch Lifecore Biomedical, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Lifecore Biomedical, Inc. stocks are traded under the ticker LFCR.
LFCR stock has risen by 9.27% compared to the previous week, the month change is a 40.04% rise, over the last year Lifecore Biomedical, Inc. has showed a −1.62% decrease.
We've gathered analysts' opinions on Lifecore Biomedical, Inc. future price: according to them, LFCR price has a max estimate of 10.00 USD and a min estimate of 6.00 USD. Watch LFCR chart and read a more detailed Lifecore Biomedical, Inc. stock forecast: see what analysts think of Lifecore Biomedical, Inc. and suggest that you do with its stocks.
LFCR reached its all-time high on Jul 2, 1996 with the price of 20.75 USD, and its all-time low was 1.51 USD and was reached on Sep 13, 2002. View more price dynamics on LFCR chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
LFCR stock is 6.73% volatile and has beta coefficient of −0.26. Track Lifecore Biomedical, Inc. stock price on the chart and check out the list of the most volatile stocks — is Lifecore Biomedical, Inc. there?
Today Lifecore Biomedical, Inc. has the market capitalization of 269.20 M, it has increased by 9.06% over the last week.
Yes, you can track Lifecore Biomedical, Inc. financials in yearly and quarterly reports right on TradingView.
Lifecore Biomedical, Inc. is going to release the next earnings report on Jan 2, 2025. Keep track of upcoming events with our Earnings Calendar.
LFCR earnings for the last quarter are −0.53 USD per share, whereas the estimation was −0.49 USD resulting in a −8.90% surprise. The estimated earnings for the next quarter are −0.29 USD per share. See more details about Lifecore Biomedical, Inc. earnings.
Lifecore Biomedical, Inc. revenue for the last quarter amounts to 24.70 M USD, despite the estimated figure of 23.19 M USD. In the next quarter, revenue is expected to reach 29.75 M USD.
LFCR net income for the last quarter is −16.23 M USD, while the quarter before that showed −7.08 M USD of net income which accounts for −129.14% change. Track more Lifecore Biomedical, Inc. financial stats to get the full picture.
No, LFCR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 24, 2024, the company has 524.00 employees. See our rating of the largest employees — is Lifecore Biomedical, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Lifecore Biomedical, Inc. EBITDA is −1.84 M USD, and current EBITDA margin is 0.63%. See more stats in Lifecore Biomedical, Inc. financial statements.
Like other stocks, LFCR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Lifecore Biomedical, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Lifecore Biomedical, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Lifecore Biomedical, Inc. stock shows the buy signal. See more of Lifecore Biomedical, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.